MOUNJARO WEIGHT LOSS INJECTION

  • Mounjaro (tirzepatide) is a medication used to lower blood sugar levels in adults with type 2 diabetes.

  • Average weight loss of 15-22.5% of body weight over 72 weeks, with some individuals experiencing greater losses when combined with lifestyle changes

  • Purpose:
    • Mounjaro activates two receptors called GLP-1 and GIP, increasing the level of incretins (hormones) in the body. It helps your body produce more insulin when needed, reduces liver glucose production, and slows down food digestion.
    • Mounjaro is administered once weekly.
  • Usage:
    • Take it alongside a reduced-calorie diet.
    • Engage in increased physical activity.
  • Eligibility: It’s intended for use in overweight or obese adults.

  • Significant weight loss potential
  • Improves blood sugar control and reduces cardiovascular risk factors
  • Once-weekly dosing for convenience

  • High incidence of gastrointestinal side effects
  • Requires gradual dose escalation to mitigate side effects
  • High cost

GI Effects

  • Nausea (20-40%)
  • Diarrhea (18-23%)
  • Vomiting (10-18%)- Constipation (10-16%)
  • Decreased appetite (10-15%)

Rare Side Effects

  • Pancreatitis (<0.1%)
  • Gallbladder problems, including gallstones (<0.5%)
  • Severe allergic reactions (anaphylaxis) (<0.1%)
  • Kidney problems (<0.1%)

Book for a Teleconsult on (+254)-111-051-530 or free Physical consultation with our team of Bariatric Specialist, Dietitian, Trainer and Counsellor